R2 CAD Panel Conditions: Postmarket Clinical Efficacy Study, Data Reanalysis

A postmarket clinical efficacy study of R2 Technology's ImageChecker CT computer-aided detection (CAD) system for lung nodules should be a requirement for FDA approval, the agency's Radiological Devices Panel recommended Feb. 3